Literature DB >> 25874497

Killing of cancer cells through the use of eukaryotic expression vectors harbouring genes encoding nucleases and ribonuclease inhibitor.

Elena M Glinka1.   

Abstract

Cancer gene therapy vectors are promising tools for killing cancer cells with the purpose of eradicating malignant tumours entirely. Different delivery methods of vectors into the cancer cells, including both non-viral and viral, as well as promoters for the targeted expression of genes encoding anticancer proteins were developed for effective and selective killing of cancer cells without harming healthy cells. Many vectors have been created to kill cancer cells, and some vectors suppress malignant tumours with high efficiency. This review is focused on vectors bearing genes for nucleases such as deoxyribonucleases (caspase-activated DNase, deoxyribonuclease I-like 3, endonuclease G) and ribonucleases (human polynucleotide phosphorylase, ribonuclease L, α-sarcin, barnase), as well as vectors harbouring gene encoding ribonuclease inhibitor. The data concerning the functionality and the efficacy of such vectors are presented.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25874497     DOI: 10.1007/s13277-015-3360-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  132 in total

1.  Targeting diphtheria toxin and TNF alpha expression in ovarian tumors using the H19 regulatory sequences.

Authors:  Aya Mizrahi; Abraham Hochberg; Smadar Amiur; Jennifer Gallula; Imad Matouk; Tatiana Birman; Tally Levy; Sorin Ladimir; Patricia Ohana
Journal:  Int J Clin Exp Med       Date:  2010-09-21

2.  Endonuclease G: a role for the enzyme in recombination and cellular proliferation.

Authors:  Ke-Jung Huang; Chia-Chi Ku; I Robert Lehman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

3.  A role of the Ca2+/Mg2+-dependent endonuclease in apoptosis and its inhibition by Poly(ADP-ribose) polymerase.

Authors:  A G Yakovlev; G Wang; B A Stoica; H A Boulares; A Y Spoonde; K Yoshihara; M E Smulson
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

Review 4.  The eight human "canonical" ribonucleases: molecular diversity, catalytic properties, and special biological actions of the enzyme proteins.

Authors:  Salvatore Sorrentino
Journal:  FEBS Lett       Date:  2010-04-11       Impact factor: 4.124

5.  Antitumor effects of human ribonuclease inhibitor gene transfected on B16 melanoma cells.

Authors:  Jun-Xia Chen; Ying Gao; Ji-Wei Liu; Yu-Xiang Tian; Jing Zhao; Xiu-Yun Cui
Journal:  Int J Biochem Cell Biol       Date:  2005-01-13       Impact factor: 5.085

Review 6.  Eukaryotic expression vectors containing genes encoding plant proteins for killing of cancer cells.

Authors:  Elena M Glinka
Journal:  Cancer Epidemiol       Date:  2013-10-21       Impact factor: 2.984

7.  Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor.

Authors:  K Kurachi; E W Davie; D J Strydom; J F Riordan; B L Vallee
Journal:  Biochemistry       Date:  1985-09-24       Impact factor: 3.162

Review 8.  Antibody-targeted RNase fusion proteins (immunoRNases) for cancer therapy.

Authors:  Jürgen Krauss; Michaela A E Arndt; Stefan Dübel; Susanna M Rybak
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

9.  The mechanism for activation of GTP hydrolysis on the ribosome.

Authors:  Rebecca M Voorhees; T Martin Schmeing; Ann C Kelley; V Ramakrishnan
Journal:  Science       Date:  2010-11-05       Impact factor: 47.728

10.  Construction of the plasmid for expression of ETA-EGFP fusion protein under control of the cytomegalovirus promoter and its effects in HeLa cells.

Authors:  Elena M Glinka; Alla S Andryushchenko; Alexander M Sapozhnikov; Olga V Zatsepina
Journal:  Plasmid       Date:  2009-06-13       Impact factor: 3.085

View more
  1 in total

Review 1.  Barnase-Barstar Pair: Contemporary Application in Cancer Research and Nanotechnology.

Authors:  Olga Shilova; Polina Kotelnikova; Galina Proshkina; Elena Shramova; Sergey Deyev
Journal:  Molecules       Date:  2021-11-10       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.